IRF
CRL icon

IBM Retirement Fund’s Charles River Laboratories CRL Stock Holding History

IBM Retirement Fund’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-792
Closed -$225K – 111
2022
Q1 		$225K Sell
792
-37
-4% -$11.4K 0.03% 478
2021
Q4 		$312K Sell
829
-586
-41% -$228K 0.04% 419
2021
Q3 		$584K Buy
1,415
+10
+0.7% +$4.15K 0.05% 371
2021
Q2 		$520K Sell
1,405
-252
-15% -$84.1K 0.04% 409
2021
Q1 		$480K Sell
1,657
-146
-8% -$40.6K 0.03% 463
2020
Q4 		$450K Buy
1,803
+216
+14% +$51.4K 0.03% 484
2020
Q3 		$359K Buy
+1,587
New +$329K 0.03% 467
2017
Q1 		– Sell
-3,719
Closed -$283K – 443
2016
Q4 		$283K Sell
3,719
-707
-16% -$53.7K 0.01% 795
2016
Q3 		$369K Sell
4,426
-289
-6% -$24.2K 0.02% 753
2016
Q2 		$389K Sell
4,715
-2
-0% -$165 0.01% 763
2016
Q1 		$358K Sell
4,717
-6,227
-57% -$461K 0.01% 763
2015
Q4 		$880K Buy
10,944
+824
+8% +$59.4K 0.02% 797
2015
Q3 		$643K Sell
10,120
-874
-8% -$62.8K 0.01% 806
2015
Q2 		$773K Sell
10,994
-478
-4% -$35.4K 0.01% 858
2015
Q1 		$910K Sell
11,472
-2
-0% -$148 0.02% 793
2014
Q4 		$730K Buy
11,474
+1,086
+10% +$68.1K 0.01% 867
2014
Q3 		$621K Sell
10,388
-1,366
-12% -$78.2K 0.01% 881
2014
Q2 		$633K Sell
11,754
-312
-3% -$17.1K 0.01% 936
2014
Q1 		$736K Sell
12,066
-7,348
-38% -$428K 0.01% 863
2013
Q4 		$1.03M Sell
19,414
-483
-2% -$24.3K 0.01% 891
2013
Q3 		$920K Sell
19,897
-2,787
-12% -$128K 0.01% 917
2013
Q2 		$931K Buy
+22,684
New +$972K 0.01% 929

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IBM Retirement Fund's CRL Position: Q2 2022 in Review

IBM Retirement Fund sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 792 shares — an estimated $225K sold.

IBM Retirement Fund first reported a position in CRL in Q2 2013 and held it in 22 quarters. The position peaked at $1.03M in Q4 2013. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

  • IBM Retirement Fund reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 792 Charles River Laboratories shares in Q2 2022, an estimated $225K.
  • IBM Retirement Fund first reported a position in Charles River Laboratories in Q2 2013 and held it in 22 quarters.
  • IBM Retirement Fund's Charles River Laboratories position peaked at $1.03M in Q4 2013.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.